KANGIO (BIVALIRUDIN) INJECTION holds 2 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals) with 2 filings. The WikiTrademarks Expansion Score is 1/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed June 23, 2026
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is KANGIO (BIVALIRUDIN) INJECTION filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Ownership & Assignment History
1 record| Date | From | To |
|---|---|---|
| Feb 18, 2026 |
EAGLE PHARMACEUTICALS, INC
|
ANKURA TRUST COMPANY, LLC
FAIRFIELD, CONNECTICUT
|
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 86851053 | KANGIO (BIVALIRUDIN) INJECTION | Dec 16, 2015 | Registered | 005 Pharmaceuticals | Eagle Pharmaceuticals, Inc. |
| 86851093 | KANGIO (BIVALIRUDIN) INJECTION | Dec 16, 2015 | Registered | 005 Pharmaceuticals | Eagle Pharmaceuticals, Inc. |
Weekly visibility reports showing how ChatGPT mentions KANGIO (BIVALIRUDIN) INJECTION, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: KANGIO (BIVALIRUDIN) INJECTION trademark portfolio
What trademarks does KANGIO (BIVALIRUDIN) INJECTION hold?
KANGIO (BIVALIRUDIN) INJECTION holds 2 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals). The most recent filings are registered to Eagle Pharmaceuticals, Inc..
How many trademarks does KANGIO (BIVALIRUDIN) INJECTION have at the USPTO?
WikiTrademarks tracks 2 USPTO trademark filings attributed to KANGIO (BIVALIRUDIN) INJECTION. The brand has been actively filing since December 2015. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does KANGIO (BIVALIRUDIN) INJECTION file most often?
KANGIO (BIVALIRUDIN) INJECTION's most active class is NICE Class 5 (Pharmaceuticals), with 2 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the KANGIO (BIVALIRUDIN) INJECTION trademark?
The most recent filings under the KANGIO (BIVALIRUDIN) INJECTION mark are registered to Eagle Pharmaceuticals, Inc.. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is KANGIO (BIVALIRUDIN) INJECTION expanding into new categories?
The current WikiTrademarks Expansion Score for KANGIO (BIVALIRUDIN) INJECTION is 1 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new KANGIO (BIVALIRUDIN) INJECTION trademark filings?
Click the Watch Brand button at the top of this page to add KANGIO (BIVALIRUDIN) INJECTION to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare KANGIO (BIVALIRUDIN) INJECTION to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about KANGIO (BIVALIRUDIN) INJECTION and help the next person researching it.